-
Product Insights
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Metabotropic Glutamate Receptor 4 Pipeline Drugs Market Report Overview Metabotropic Glutamate Receptor 4 is a protein encoded by the GRM4 gene. It is a G-protein coupled receptor for glutamate. Glutamate binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. The Metabotropic Glutamate Receptor 4 (MGLUR4) drugs market research report provides comprehensive information on the MGLUR4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action...
-
Product Insights
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
SMN Protein Pipeline Products Market Report Overview Survival of motor neurons or survival motor neurons (SMN) is a protein encoded by the SMN1 and SMN2 genes. The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs). They play an important role in the splicing of cellular pre-mRNAs. They ensure the correct splicing of U12 intron-containing genes that is important for normal motor and proprioceptive neuron development. They are required for resolving RNA-DNA hybrids created by...
-
Product Insights
Toll Like Receptor 4 (hToll or CD284 or TLR4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Toll Like Receptor 4 Pipeline Drugs Market Report Overview Toll-like receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly expressed in the placenta and the myelomonocytic subpopulation of leukocytes. It is involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni2+. The Toll Like Receptor 4 (TLR4) pipeline drugs market research report provides comprehensive information on the TLR4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of...
-
Product Insights
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Interleukin 7 Receptor Subunit Alpha Pipeline Drugs Market Report Overview Interleukin-7 receptor is a protein found on the surface of cells. It acts as a receptor for thymic stromal lymphopoietin (TSLP) and plays an important role in T-cell acute lymphoblastic leukemia, multiple sclerosis, rheumatoid arthritis, and juvenile idiopathic arthritis. The Interleukin 7 Receptor Subunit Alpha pipeline drugs market research report provides comprehensive information on the Interleukin 7 Receptor Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development,...
-
Product Insights
Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Serine/Threonine Protein Kinase A Raf Pipeline Products Market Report Overview Serine/threonine-protein kinase A-Raf is an enzyme that in humans is encoded by the ARAF gene. It is involved in the transduction of mitogenic signals from the cell membrane to the nucleus. It regulates the TOR signaling cascade. The Serine/Threonine Protein Kinase A Raf pipeline market research report provides comprehensive information on the therapeutics under development for Serine/Threonine Protein Kinase A Raf, complete with analysis by stage of development, drug target,...
-
Product Insights
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alpha 2C Adrenergic Receptor Pipeline Drugs Market Report Overview Alpha-2C Adrenergic Receptor or ADRA2C is an alpha-2 adrenergic receptor that mediates the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. This receptor plays a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. The Alpha 2C Adrenergic Receptor (ADRA2C) pipeline drugs market research report provides comprehensive information on the ADRA2C targeted therapeutics, complete with analysis by indications, stage...
-
Product Insights
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leptin Receptor Pipeline Drugs Market Report Overview Leptin Receptor or LEP-R is a protein encoded by the LEPR gene. It acts as a receptor for the hormone LEP/leptin. Upon binding it mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade. The Leptin Receptor pipeline drugs market research report provides comprehensive information on the Leptin Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route...
-
Product Insights
Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alpha N-acetylglucosaminidase Pipeline Products Market Report Overview Alpha N-acetylglucosaminidase is a protein associated with Sanfilippo syndrome. This enzyme is located in lysosome compartments within cells that digest and recycle different types of molecules. Alpha N-acetylglucosaminidase is involved in the stepwise breakdown of large molecules called glycosaminoglycans (GAGs). Alpha N-acetylglucosaminidase removes a sugar called N-acetylglucosamine when it is at the end of the GAG chain. The Alpha N-Acetylglucosaminidase pipeline market research report provides comprehensive information on the therapeutics under development for...
-
Product Insights
Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ephrin Type B Receptor 4 Pipeline Drugs Market Report Overview Ephrin type-B receptor 4 is a protein encoded by the EPHB4 gene. It binds promiscuously to transmembrane ephrin-B family ligands residing on adjacent cells which leads to contact dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. It plays a central role in heart morphogenesis...
-
Product Insights
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Integrin Beta 7 Pipeline Drugs Market Report Overview Integrin beta-7 is an integrin protein encoded by the ITGB7 gene. It interacts with the cell surface adhesion molecules MADCAM1, which is normally expressed by the vascular endothelium of the gastrointestinal tract. The Integrin Beta 7 pipeline drugs market research report provides comprehensive information on the Integrin Beta 7 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.